July 29, 2016 2:21 AM ET

Biotechnology

Company Overview of miRagen Therapeutics, Inc.

Key Executives for miRagen Therapeutics, Inc.

NameBoard RelationshipsTitleAge
William S. Marshall Ph.D.34 RelationshipsCo-Founder, Chief Executive Officer, President and Director--
Bruce L. Booth D.Phil., Ph.D.114 RelationshipsCo-Founder and Chairman of The Board 42
Michael R. Bristow M.D., Ph.D.17 RelationshipsCo-Founder and Member of the Scientific Advisory Board71
Marvin H. Caruthers Ph.D.48 RelationshipsCo-Founder and Director76
Eric N. Olson Ph.D.62 RelationshipsCo-Founder and Member of Scientific Advisory Board--
View More Key Executives

miRagen Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Bruce L. Booth D.Phil., Ph.D. 114 RelationshipsmiRagen Therapeutics, Inc.42
William S. Marshall Ph.D. 34 RelationshipsmiRagen Therapeutics, Inc.--
Eric N. Olson Ph.D. 62 RelationshipsmiRagen Therapeutics, Inc.--
Michael R. Bristow M.D., Ph.D. 17 RelationshipsARCA biopharma, Inc.71
Marvin H. Caruthers Ph.D. 48 RelationshipsmiRagen Therapeutics, Inc.76
View All Board Members

miRagen Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
381.0K
Bonus
261.1K
Total Short Term Compensation
476.1K
Total Value of Options
34.0M
Compensation as of Fiscal Year
miRagen Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Seattle Genetics Announces Executive Changes
July 27, 2016 10:43 PM ET
Advanced Accelerator Applications S.A. Appoints Francois Nader as an Independent Non-Executive Director Replacing Muriel De Szilbereky
July 27, 2016 9:10 PM ET
Vitae Pharmaceuticals, Inc. Announces Board Changes
July 27, 2016 8:41 PM ET
Biocept, Inc. Announces Executive Changes
July 27, 2016 12:05 PM ET
Syndax Pharmaceuticals, Inc. Appoints Board of Directors
July 27, 2016 11:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact miRagen Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.